KRRO
COM:KORROBIO
Korro Bio
- Stock
Last Close
35.03
25/09 14:35
Market Cap
385.94M
Beta: -
Volume Today
20.87K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|
average inventory | -72K - | -72K 0% | ||
average payables | 3.15M - | 1.70M 46.08% | 4.94M 191.25% | |
average receivables | 242K - | 72K 70.25% | ||
book value per share | -5.28 - | -12.38 134.63% | 111.10 997.66% | |
capex per share | -0.56 - | -0.65 17.20% | -5.12 686.59% | |
capex to depreciation | -2.79 - | -2.08 25.55% | -2.16 4.00% | |
capex to operating cash flow | 0.14 - | 0.10 29.88% | 0.12 19.87% | |
capex to revenue | -0.32 - | |||
cash per share | 14.81 - | 6.90 53.39% | 108.64 1,473.42% | |
days of inventory on hand | -13.68 - | |||
days payables outstanding | 74.98 - | 378.66 405.04% | 732.01 93.31% | |
days sales outstanding | 3.74 - | |||
debt to assets | 0.13 - | 0.04 67.67% | 0.15 252.94% | |
debt to equity | -0.40 - | -0.03 92.03% | 0.20 718.35% | |
dividend yield | ||||
earnings yield | -0.01 - | -0.04 252.14% | -1.08 2,766.79% | |
enterprise value | 2.01B - | 1.51B 25.19% | -57.79M 103.83% | |
enterprise value over ebitda | -59.42 - | -26.68 55.10% | 0.71 102.68% | |
ev to operating cash flow | -62.77 - | -28.09 55.24% | 0.86 103.06% | |
ev to sales | 143.19 - | |||
free cash flow per share | -4.57 - | -7.36 61.07% | -49.12 567.75% | |
free cash flow yield | -0.02 - | -0.04 114.62% | -1.00 2,515.82% | |
graham net net | -6.40 - | -14.69 129.47% | 74.80 609.27% | |
graham number | 18.05 - | 44.94 149.01% | 364.26 710.50% | |
income quality | 1.46 - | 0.92 36.75% | 0.83 10.33% | |
intangibles to total assets | 0 - | 0 | 0 | |
interest coverage | -499.98 - | |||
interest debt per share | 2.09 - | 0.41 80.61% | 21.71 5,249.02% | |
inventory turnover | -26.67 - | |||
invested capital | -0.40 - | -0.03 92.03% | 0.20 718.35% | |
market cap | 2.05B - | 1.54B 24.95% | 75.15M 95.12% | |
net current asset value | -50.01M - | -115.69M 131.34% | 120.98M 204.57% | |
net debt to ebitda | 1.12 - | 0.59 47.42% | 1.64 179.55% | |
net income per share | -2.74 - | -7.25 164.27% | -53.08 631.81% | |
operating cash flow per share | -4.01 - | -6.70 67.15% | -44.00 556.20% | |
payables turnover | 4.87 - | 0.96 80.20% | 0.50 48.27% | |
receivables turnover | 97.69 - | |||
research and ddevelopement to revenue | 1.69 - | |||
return on tangible assets | -0.17 - | -0.79 357.20% | -0.37 53.47% | |
revenue per share | 1.76 - | |||
roe | 0.52 - | 0.59 12.64% | -0.48 181.52% | |
roic | -10.47 - | 0.64 106.07% | -0.36 156.26% | |
sales general and administrative to revenue | 0.83 - | |||
shareholders equity per share | -5.28 - | -12.38 134.63% | 111.10 997.66% | |
stock based compensation to revenue | 0.06 - | |||
tangible asset value | -42.21M - | -99.03M 134.63% | 169.91M 271.57% | |
tangible book value per share | -5.28 - | -12.38 134.63% | 111.10 997.66% | |
working capital | 114.83M - | 48.38M 57.86% | 153.25M 216.74% |
All numbers in (except ratios and percentages)